Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
TEVA PHARMACEUTICAL INDUSTRIES LTD | EVP, Business Development | Ordinary Shares | 8.85K | $153K | $17.28 | Aug 9, 2024 | Direct |
TEVA PHARMACEUTICAL INDUSTRIES LTD | EVP, Business Development | Restricted Share Units | 52.1K | Mar 4, 2024 | Direct | ||
TEVA PHARMACEUTICAL INDUSTRIES LTD | EVP, Business Development | Restricted Share Units | 38.7K | Aug 9, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Aug 9, 2024 | 3 | -$70.2K | 4 | Aug 13, 2024 | EVP, Business Development |
TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Mar 4, 2024 | 1 | $0 | 4 | Mar 5, 2024 | EVP, Business Development |
TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Aug 9, 2023 | 1 | $0 | 4 | Aug 10, 2023 | EVP, Business Development |
TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Aug 1, 2023 | 0 | $0 | 3 | Aug 10, 2023 | EVP, Business Development |